BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24666524)

  • 1. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
    Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
    BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
    Raoof N; Quhill F
    Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
    Ramasubramanian A; Shields CL
    Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adjuvant anti-VEGF therapy in Coats' disease].
    Fiorentzis M; Stavridis E; Seitz B; Viestenz A
    Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab injections combined with laser photocoagulation for adult-onset Coats' disease.
    Park S; Cho HJ; Lee DW; Kim CG; Kim JW
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1511-1517. PubMed ID: 26631136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined photodynamic therapy and intravitreal bevacizumab injection for the treatment of adult Coats' disease: a case report.
    Kim J; Park KH; Woo SJ
    Korean J Ophthalmol; 2010 Dec; 24(6):374-6. PubMed ID: 21165239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
    Wang KY; Cheng CK
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intravitreal bevacizumab in adult onset Coats' disease.
    Goel N; Kumar V; Seth A; Raina UK; Ghosh B
    Int Ophthalmol; 2011 Jun; 31(3):183-90. PubMed ID: 21437759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal dexamethasone implant with retinal photocoagulation for adult-onset Coats' disease.
    Kumar K; Raj P; Chandnani N; Agarwal A
    Int Ophthalmol; 2019 Feb; 39(2):465-470. PubMed ID: 29380183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
    Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
    Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retinal exudative disease in childhood: Coats' disease and familial exudative vitreoretinopathy (FEVR)].
    Joussen AM; Gordes RS; Heußen FA; Müller B
    Klin Monbl Augenheilkd; 2013 Sep; 230(9):902-13. PubMed ID: 23986189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Coats' Disease With Combination Therapy of Intravitreal Bevacizumab, Laser Photocoagulation, and Sub-Tenon Corticosteroids.
    Sein J; Tzu JH; Murray TG; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):443-9. PubMed ID: 27183548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease.
    Zhang L; Ke Y; Wang W; Shi X; Hei K; Li X
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1339-1346. PubMed ID: 29549425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
    Lin CJ; Chen SN; Hwang JF; Yang CM
    J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INTRAVITREAL RANIBIZUMAB INJECTION AND RETINAL LASER PHOTOCOAGULATION TREATMENT FOR ADULT-ONSET COATS DISEASE.
    Plaza-Laguardia C; Pascual-Camps I; Bayón-Porras MR; Sánchez-Cañizal J; Gallego-Pinazo R
    Retin Cases Brief Rep; 2021 Sep; 15(5):532-535. PubMed ID: 31913217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
    Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
    Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
    Bhat V; D'Souza P; Shah PK; Narendran V
    Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual outcomes after treatment in pediatric patients with Coats' disease.
    Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
    Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset coats' disease initially treated as unilateral ROP at 39 weeks postmenstrual age: a case report.
    Peng J; Zhang Q; Chen C; Huang Q; Li Y; Zhao P
    BMC Ophthalmol; 2017 Aug; 17(1):145. PubMed ID: 28814287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.
    Jun JH; Kim YC; Kim KS
    Korean J Ophthalmol; 2008 Sep; 22(3):190-3. PubMed ID: 18784449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.